Lisinopril And Hydrochlorothiazide Tablet
Product Images NDC 43063-482
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Lisinopril And Hydrochlorothiazide (NDC 43063-482). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
3a53f18e Af9b 4932 8300 B3521e87528d 02
Image (43063482)
This is a pharmaceutical label for LISINOPRIL/HCTZ tablets containing 10mg/12.5mg strength. The label includes dosage and storage information, expiration date, lot number, and reorder number. The warning advises to keep it out of the reach of children. There is a disclaimer to consult a doctor for medical advice about side effects and also mentions the possibility of reporting side effects to the FDA. The label also includes a caution that if pregnancy is detected, the medication should be discontinued.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.